col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Journal of Investigative Dermatology
  original article Date Title Authors   All Authors
1 [GO] 2021―Oct―08 067 BELCOMID: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases T. Hillary, A. Van Laethem, F. Castelijns, S. Vermeire, J. Geldof, M. Ferrante, et al. (+6)
2 [GO] 2021―Oct―08 072 Covid-19 and male androgenetic alopecia: Systematic investigation of a potential epidemiological and genetic association S.K. Henne, L.M. Hochfeld, C. Maj, M.M. Nöthen, S. Heilmann-Heimbach
3 [GO] 2021―Oct―08 065 Application of teledermatology during the first wave of the COVID-19 pandemic in Hungary A. Jobbágy, F. Meznerics, K. Farkas, S. Bozsányi, L. Fesus, N. Kiss, et al. (+4)
4 [GO] 2021―Oct―08 055 The impact of methotrexate and targeted immunosuppression on cellular and humoral immune responses to COVID-19 vaccine BNT162b2: a cohort study S.K. Mahil, K. Bechman, A. Raharja, C. Domingo-Vila, M. Brown, A. Cope, et al. (+9)
5 [GO] 2021―Oct―08 245 Demodex folliculorum interaction with SARS-CoV2 from a chitin-lipid perspective A.L. Tatu, T. Nadasdy, F.C. Bujoreanu, D. Radaschin, L.C. Nwabudike
6 [GO] 2021―Aug―19 LB761 Clinical outcomes in Pemphigoid and Pemphigus patients with COVID-19 H. Pakhchanian, R. Raiker, J. Wang, K. Phan
7 [GO] 2021―Aug―19 LB751 COVID-19 complications in patients with Hidradenitis Suppurativa: A multicenter study R. Raiker, H. Pakhchanian, K. Phan
8 [GO] 2021―Aug―19 LB767 A multicenter analysis of patients using telemedicine for dermatological conditions during the COVID-19 pandemic R. Raiker, H. Pakhchanian, M. Baker, E. Hochman, M. Deng
9 [GO] 2021―Aug―19 LB723 Face skin changes caused by face mask during the COVID-19 pandemic S. Park, J. Han, Y. Yeong, N. Kang, B. SUH, E. Kim
10 [GO] 2021―Aug―19 LB768 Adult and pediatric emergency department visits for dermatological conditions during the COVID-19 pandemic: A multicenter analysis H. Pakhchanian, R. Raiker, K. Russomanno, M. Deng
11 [GO] 2021―Aug―19 LB771 Racial and Ethnic Disparities in COVID-19-Related Infection in Patients with Psoriasis: A Cross-Sectional Study C. Nguyen, S. Shwe, K. Yale, A. Ghigi, K. Zheng, N. Mesinkovska, T. Bhutani
12 [GO] 2021―Aug―19 LB740 SARS-CoV-2-associated ‘covid toes:’ multiplex immunofluorescent characterization of pathophysiology J.J. Moon, A. Costa da Silva, J.M. Tran, C. Kim, R. Sharma, M. Hinshaw, et al. (+7)
13 [GO] 2021―Aug―04 Assessing the risk and outcome of COVID-19 in patients with psoriasis or psoriatic arthritis on biologic treatment: a critical appraisal of the quality of the published evidence Stefano Piaserico, Paolo Gisondi, Simone Cazzaniga, Sara Di Leo, Luigi Naldi
14 [GO] 2021―Jul―15 From your nose to your toes: A Review of SARS-CoV-2 Pandemic-associated Pernio Lisa M. Arkin, John J. Moon, Jennifer M. Tran, Samira Asgari, Cliona O’Farrelly, Jean-Laurent Casanova, et al. (+4)
15 [GO] 2021―Apr―19 255 The risk of contracting COVID-19 after dermatological procedures compared with other medical procedures R. Raiker, H. Pakhchanian, A. Baghdjian, V.A. Patel
16 [GO] 2021―Apr―19 336 Risks of COVID-19 infection and mortality for patients on biologics V. Pahalyants, W. Murphy, N. Klebanov, N. Theodosakis, M. Klevens, E. Lilly, et al. (+2)
17 [GO] 2021―Apr―19 028 Use of systemic immunosuppressive treatment is not related to COVID-19 infection in a retrospective review of patients in Massachusetts W. Murphy, N. Klebanov, V. Pahalyants, N. Theodosakis, K. Patel, M. Klevens, et al. (+2)
18 [GO] 2021―Apr―19 316 The impact of COVID-19 on gender representation in academic dermatology publications M.D. Szeto, M. Laughter, M.B. Maymone, T.E. Sivesind, C.L. Presley, S.M. Lada, et al. (+2)
19 [GO] 2021―Apr―19 652 Using implementation science to understand teledermatology during the COVID-19 pandemic S. Briggs, J. Lipoff, S. Collier
20 [GO] 2021―Apr―19 391 Public sunscreen dispensers and consumer sunscreen trends during the COVID-19 pandemic J. Maghfour, C. Rundle, M.D. Szeto, C.L. Presley, C. Eason, C. Dunnick, et al. (+2)
21 [GO] 2021―Apr―19 281 Racial and language disparities in teledermatology visits for acne during the COVID-19 pandemic M.S. Lee, B. Kassamali, N. Shah, A. Lachance, V. Nambudiri
22 [GO] 2021―Apr―19 461 A review of cutaneous lymphoma outcomes during COVID-19 pandemic at Columbia University T. Garcia-Saleem, C. Stonesifer, L. Geskin
23 [GO] 2021―Apr―19 433 Increased risk of hospital acquired sacral pressure injuries in COVID-19 patients J. Narang, J. Gallop, S. Seck, A.H. Wei, A.S. Nowacki, A.P. Fernandez
24 [GO] 2021―Apr―19 441 Cutaneous findings in COVID-19 patients hospitalized at a large urban academic medical center S. Chand, R. Rrapi, J. Lo, C. Gabel, S. Song, Z. Holcomb, et al. (+9)
25 [GO] 2021―Apr―19 342 Clinical outcomes in COVID-19 patients with Atopic dermatitis H. Pakhchanian, R. Raiker, V.A. Patel
26 [GO] 2021―Apr―19 338 Clinical outcomes in COVID-19 patients with dermatopolymyositis H. Pakhchanian, R. Raiker, A. Qureshi, V.A. Patel
27 [GO] 2021―Apr―19 243 Clinical outcomes in COVID-19 patients with varicella zoster virus R. Raiker, H. Pakhchanian, A. Gonzalez Lopez, V.A. Patel
28 [GO] 2021―Apr―19 011 Systemic hyperinflammation as a driver of maculopapular drug exanthema in severely ill COVID-19 patients? Y. Mitamura, D. Schulz, I. Kolm, S. Oro, M. Levesque, E. Maverakis, et al. (+2)
29 [GO] 2021―Apr―19 254 COVID-19 related outcomes in psoriasis and psoriasis arthritis patients R. Raiker, H. Pakhchanian, V.A. Patel
30 [GO] 2021―Apr―19 032 A multicomponent skin-targeted COVID-19 vaccine elicits robust humoral and cellular immune responses S.C. Balmert, Z.G. Ghozloujeh, C.D. Carey, T.L. Sumpter, G. Erdos, E. Korkmaz, L.D. Falo
31 [GO] 2021―Apr―19 381 Perspective of psoriatic disease patients on novel COVID-19 vaccines G. Gondo, S. Heydon, S. Bell
32 [GO] 2021―Apr―19 205 Evaluation of SARS-CoV-2 spike protein response on PI3K agonist-mediated IL-8 release C.E. Borchers, A. Thyagarajan, C. Rapp, J.B. Travers, R. Sahu
33 [GO] 2021―Apr―19 332 National trends of dermatology procedures during the COVID pandemic R. Raiker, H. Pakhchanian, K. Alam, A. Hakopian, V.A. Patel
34 [GO] 2021―Apr―19 335 Trends in dermatological prescribing patterns during the COVID pandemic H. Pakhchanian, R. Raiker, K. Alam, A. Hou, V.A. Patel
35 [GO] 2021―Apr―19 331 Trends and outcomes in patients with malignant skin cancers during the COVID pandemic R. Raiker, H. Pakhchanian, A. Hussain, M. Deng
36 [GO] 2021―Apr―19 677 Personal protective equipment needs during the COVID-19 pandemic: A survey of medical dermatologists S. Chand, R. Rrapi, C. Gabel, Y. Levin, V. Neel, D. Kroshinsky
37 [GO] 2020―Oct―15 ACE2 expression on the keratinocytes and SARS-CoV-2 percutaneous transmission, are they related? Ruixuan Zhu, Yaqian Shi, Yixin Tan, Rong Xiao
38 [GO] 2020―Sep―02 Clinical research post COVID-19: Embracing a new normal Joel M. Gelfand, Brooke E. Hefele
39 [GO] 2020―Aug―14 The Impact of Covid-19 on Dermatology Clinical Trials Sheena Desai, Priya Manjaly, Karen Lee, Sara J. Li, Cyriac Manjaly, Arash Mostaghimi
40 [GO] 2020―May―23 High expression of ACE2 on the keratinocytes reveals skin as a potential target for SARS-CoV-2 Xiaotong Xue, Zihao Mi, Zhenzhen Wang, Zheng Pang, Hong Liu, Furen Zhang


[de][en]

Last change 2022―Jan―20 20:43:25 UTC

© Daten-Quadrat 2022       Done in 0.005 sec